Exploiting
MET
dysregulation in
EGFR
-addicted non-small-cell lung carcinoma: a further step toward personalized medicine
Transl Lung Cancer Res
.
2018 Dec;7(Suppl 4):S312-S317.
doi: 10.21037/tlcr.2018.12.08.
Authors
Vincenzo Di Noia
1
,
Ettore D'Argento
1
,
Sara Pilotto
2
,
Miriam Grazia Ferrara
1
,
Michele Milella
2
,
Giampaolo Tortora
1
,
Emilio Bria
1
Affiliations
1
U.O.C. Medical Oncology, Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.
2
U.O.C. Oncology, Azienda Ospedaliera Universitaria Integrata, University and Hospital Trust of Verona, Verona, Italy.
PMID:
30705843
PMCID:
PMC6328682
DOI:
10.21037/tlcr.2018.12.08
No abstract available
Publication types
Editorial
Comment